Scientists have slowed the progression of Huntington’s disease for the first time with a “groundbreaking” new treatment.
Scientists have slowed the progression of Huntington’s disease for the first time with a “groundbreaking” new treatment.
The gene therapy company uniQure has announced top-level data from its trial of AMT-130, a new gene therapy designed to treat ...
PsyPost on MSN
Scientists discover a key mechanism for dopamine to regulate brain activity and movement
A new study published in Brain Sciences provides evidence that dopamine promotes movement by directly altering the excitability of key neurons in the brain’s motor circuitry. The research identifies a ...
A global clinical trial for a new Huntington's disease treatment has posted positive results today, announced by trial sponsor uniQure and UCL ...
Pivotal study met primary endpoint; high-dose AMT-130 demonstrated statistically significant 75% disease slowing at 36 months as measured by ...
Global Sumud Flotilla reports harassment near Greece; UN calls for a probe as European ships move to safeguard civilians at ...
In an update from uniQure, they report that their experimental gene therapy, AMT-130, has the potential to slow Huntington’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback